StockGlow

GenSight Biologics S.A. (GSGTF)

Develops gene therapies to restore vision in people with inherited eye diseases and neurological disorders.

$0.09+0.00%Healthcare
Compare GSGTF with
StockGlow Score
3
Bearish
BearishBullish
1 year ago-62.5%

The outlook

GSGTF is trading near its 52-week low at $0.09, well below both its 50- and 200-day moving averages, signaling a downtrend. Analyst coverage appears minimal based on available data. The stock's current positioning reflects sustained weakness over recent months.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$21.1M
52-wk high
$0.45
52-wk low
$0.09
50-day avg
$0.13
200-day avg
$0.18
Trailing P/E
—

Similar stocks

SLUNFSolutions 30 SE$9.19+223.59%ECXJCXJ Group Co., Limited$1.50+11.09%GLHDPSH Group Holding, Inc.$0.00+0.00%WTRNFWestern Resources Corp.$0.00+0.00%PRWYFProdways Group SA$3.40+294.20%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy